Latest Insider Transactions at Mirum Pharmaceuticals, Inc. (MIRM)
This section provides a real-time view of insider transactions for Mirum Pharmaceuticals, Inc. (MIRM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mirum Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mirum Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 03
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
477
-16.43%
|
$23,373
$49.08 P/Share
|
|
Jul 02
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
564
-16.27%
|
$27,072
$48.25 P/Share
|
|
Jul 01
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,041
+23.09%
|
-
|
|
Jun 11
2025
|
William Fairey |
SELL
Open market or private sale
|
Direct |
3,203
-56.16%
|
$153,744
$48.42 P/Share
|
|
Jun 03
2025
|
Saira Ramasastry |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$112,500
$45.74 P/Share
|
|
Jun 03
2025
|
Saira Ramasastry |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$35,000
$14.12 P/Share
|
|
Jun 02
2025
|
Saira Ramasastry |
SELL
Open market or private sale
|
Direct |
5,703
-100.0%
|
$262,338
$46.2 P/Share
|
|
May 29
2025
|
Saira Ramasastry |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+50.0%
|
-
|
|
May 29
2025
|
William Fairey |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+50.0%
|
-
|
|
May 29
2025
|
Laura Brege |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+26.64%
|
-
|
|
May 29
2025
|
Patrick J Heron |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+50.0%
|
-
|
|
May 29
2025
|
Timothy P Walbert |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+50.0%
|
-
|
|
May 29
2025
|
Lon Cardon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+50.0%
|
-
|
|
Mar 18
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
2,415
-49.89%
|
$106,260
$44.45 P/Share
|
|
Mar 17
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
27,279
-16.44%
|
$1,200,276
$44.21 P/Share
|
|
Mar 17
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
7,879
-29.68%
|
$346,676
$44.21 P/Share
|
|
Mar 17
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
57,606
-42.81%
|
$2,534,664
$44.41 P/Share
|
|
Mar 17
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
52,900
+47.04%
|
$105,800
$2.94 P/Share
|
|
Mar 17
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
21
+0.01%
|
$903
$43.93 P/Share
|
|
Mar 15
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+23.16%
|
-
|
|
Mar 15
2025
|
Peter Radovich PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,440
+35.23%
|
-
|
|
Mar 15
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,315
+35.76%
|
-
|
|
Mar 14
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
528
+0.31%
|
$23,232
$44.11 P/Share
|
|
Mar 11
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
963
+0.57%
|
$41,409
$43.77 P/Share
|
|
Mar 10
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
1,335
+0.4%
|
$57,405
$43.01 P/Share
|
|
Mar 07
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
580
+0.35%
|
$24,940
$43.21 P/Share
|
|
Mar 06
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
1,335
+0.8%
|
$57,405
$43.89 P/Share
|
|
Mar 05
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
267
+0.16%
|
$11,748
$44.55 P/Share
|
|
Mar 04
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
1,335
+0.41%
|
$60,075
$45.75 P/Share
|
|
Mar 04
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
14,850
-29.77%
|
$668,250
$45.66 P/Share
|
|
Mar 03
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
40,000
-13.77%
|
$1,840,000
$46.9 P/Share
|
|
Mar 03
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+20.42%
|
$80,000
$2.94 P/Share
|
|
Feb 03
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
1,064
-20.09%
|
$51,072
$48.22 P/Share
|
|
Feb 03
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
9,102
-7.28%
|
$436,896
$48.22 P/Share
|
|
Feb 03
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
2,627
-8.88%
|
$126,096
$48.22 P/Share
|
|
Jan 31
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,772
+25.07%
|
-
|
|
Jan 24
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
3,177
-9.7%
|
$149,319
$47.92 P/Share
|
|
Jan 24
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6,837
-5.19%
|
$321,339
$47.92 P/Share
|
|
Jan 24
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
902
-20.38%
|
$42,394
$47.92 P/Share
|
|
Jan 23
2025
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,667
+6.91%
|
-
|
|
Jan 23
2025
|
Peter Radovich PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,750
+14.93%
|
-
|
|
Jan 23
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+8.66%
|
-
|
|
Jan 23
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+25.31%
|
-
|
|
Jan 17
2025
|
Joanne Quan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,969
-55.23%
|
$313,605
$45.86 P/Share
|
|
Jan 16
2025
|
Joanne Quan CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+49.77%
|
-
|
|
Jan 07
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,489
-5.9%
|
$314,538
$42.82 P/Share
|
|
Jan 07
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
1,998
-6.89%
|
$83,916
$42.82 P/Share
|
|
Jan 07
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
750
-20.4%
|
$31,500
$42.82 P/Share
|
|
Jan 06
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+25.38%
|
-
|
|
Nov 14
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
2,500
-50.75%
|
$117,500
$47.1 P/Share
|